• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后外阴和阴道萎缩女性性交困难的认知:REVIVE调查结果

Perceptions of dyspareunia in postmenopausal women with vulvar and vaginal atrophy: findings from the REVIVE survey.

作者信息

Freedman Murray A

出版信息

Womens Health (Lond). 2014 Jul;10(4):445-54. doi: 10.2217/whe.14.29.

DOI:10.2217/whe.14.29
PMID:25259904
Abstract

Symptoms of vulvar and vaginal atrophy (VVA), including dyspareunia and vaginal dryness, have a distinct negative impact on a woman's quality of life. The REVIVE survey highlighted the lack of awareness of VVA symptoms among postmenopausal women with vaginal symptoms, with many women reluctant to initiate discussions with their healthcare professionals despite the presence of vaginal symptoms. The REVIVE survey also provided insights into women's views of VVA treatments. Women reported displeasure with the vaginal administration route, lack of symptom relief with over-the-counter products, and concerns about the safety of estrogen therapies. With the high prevalence of VVA, obstetricians/gynecologists should become vigilant in identifying women with VVA by implementing screening and discussion of symptoms during routine office visits - providing patients with information about appropriate therapies based on the severity and impact of symptoms, keeping in mind individual preferences and perceptions.

摘要

外阴和阴道萎缩(VVA)的症状,包括性交困难和阴道干燥,对女性的生活质量有明显的负面影响。REVIVE调查凸显了有阴道症状的绝经后女性对VVA症状缺乏认知,尽管存在阴道症状,但许多女性仍不愿与医疗保健专业人员展开讨论。REVIVE调查还深入了解了女性对VVA治疗的看法。女性报告了对阴道给药途径不满意、非处方产品无法缓解症状以及对雌激素疗法安全性的担忧。鉴于VVA的高患病率,妇产科医生应提高警惕,通过在常规门诊中进行筛查和症状讨论来识别患有VVA的女性——根据症状的严重程度和影响,为患者提供有关适当治疗的信息,同时牢记个人偏好和认知。

相似文献

1
Perceptions of dyspareunia in postmenopausal women with vulvar and vaginal atrophy: findings from the REVIVE survey.绝经后外阴和阴道萎缩女性性交困难的认知:REVIVE调查结果
Womens Health (Lond). 2014 Jul;10(4):445-54. doi: 10.2217/whe.14.29.
2
Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.绝经后妇女的外阴和阴道萎缩:REVIVE(真实女性对绝经后阴道变化治疗选择的观点)调查的结果。
J Sex Med. 2013 Jul;10(7):1790-9. doi: 10.1111/jsm.12190. Epub 2013 May 16.
3
Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.四个欧洲国家的外阴和阴道萎缩:来自欧洲REVIVE调查的证据。
Climacteric. 2016 Apr;19(2):188-97. doi: 10.3109/13697137.2015.1107039. Epub 2015 Nov 19.
4
Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions.西班牙REVIVE研究参与者眼中的外阴和阴道萎缩:症状、管理及治疗认知
Climacteric. 2017 Feb;20(1):55-61. doi: 10.1080/13697137.2016.1262840. Epub 2017 Jan 2.
5
The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate.女性赋权调查:女性对外阴和阴道萎缩治疗方案的知识和认知仍然不足。
J Sex Med. 2017 Mar;14(3):425-433. doi: 10.1016/j.jsxm.2017.01.011. Epub 2017 Feb 12.
6
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey.意大利绝经后女性对外阴和阴道萎缩的态度与认知:来自欧洲REVIVE调查的证据。
Maturitas. 2016 Sep;91:74-80. doi: 10.1016/j.maturitas.2016.06.009. Epub 2016 Jun 11.
7
The REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: Country-specific comparisons of postmenopausal women's perceptions, experiences and needs.欧洲的REVIVE(绝经后阴道变化治疗选择的真实女性观点)调查:绝经后女性认知、经历和需求的国别比较
Maturitas. 2016 Sep;91:81-90. doi: 10.1016/j.maturitas.2016.06.010. Epub 2016 Jun 15.
8
Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data.意大利绝经后女性对外阴和阴道萎缩的态度及经历的宏观区域差异:REVIVE调查数据的事后分析
Gynecol Endocrinol. 2017 May;33(5):389-394. doi: 10.1080/09513590.2017.1284783. Epub 2017 Feb 21.
9
Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause.奥培米芬治疗绝经引起的外阴和阴道萎缩相关性交困难的安全性和有效性。
Clin Interv Aging. 2014 Nov 13;9:1939-50. doi: 10.2147/CIA.S73753. eCollection 2014.
10
The Women's EMPOWER Survey: Identifying Women's Perceptions on Vulvar and Vaginal Atrophy and Its Treatment.女性赋权调查:了解女性对外阴和阴道萎缩及其治疗的看法。
J Sex Med. 2017 Mar;14(3):413-424. doi: 10.1016/j.jsxm.2017.01.010. Epub 2017 Feb 12.

引用本文的文献

1
The Concept behind the Suitability of Menstrual Blood-Derived Stem Cells for the Management of Vaginal Atrophy among BRCA Mutation Carriers after RRSO.BRCA 基因突变携带者 RRSO 后管理阴道萎缩中月经血源性干细胞适用性的概念。
Int J Mol Sci. 2024 Jan 14;25(2):1025. doi: 10.3390/ijms25021025.
2
Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms: A Randomized Clinical Trial.阴道用雌激素或阴道润滑剂与安慰剂治疗绝经后外阴阴道症状的疗效:一项随机临床试验。
JAMA Intern Med. 2018 May 1;178(5):681-690. doi: 10.1001/jamainternmed.2018.0116.
3
Symptoms of menopause - global prevalence, physiology and implications.
更年期症状——全球患病率、生理学及影响。
Nat Rev Endocrinol. 2018 Apr;14(4):199-215. doi: 10.1038/nrendo.2017.180. Epub 2018 Feb 2.
4
The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy.REJOICE试验:一项3期随机对照试验,评估新型阴道雌二醇软胶囊治疗有症状的外阴和阴道萎缩的安全性和有效性。
Menopause. 2017 Apr;24(4):409-416. doi: 10.1097/GME.0000000000000786.